Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-12-000118
Filing Date
2012-01-12
Accepted
2012-01-12 14:16:46
Documents
11
Period of Report
2011-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk1210890.htm 10-Q 610112
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 14965
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 14836
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 7246
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 8027
  Complete submission text file 0001178913-12-000118.txt   2025410

Data Files

Seq Description Document Type Size
6 INSTANCE DOCUMENT ormp-20111130.xml EX-101.INS 161003
7 TAXONOMY EXTENSION SCHEMA ormp-20111130.xsd EX-101.SCH 16110
8 TAXONOMY EXTENSION CALCULATION LINKBASE ormp-20111130_cal.xml EX-101.CAL 37762
9 TAXONOMY EXTENSION LABEL LINKBASE ormp-20111130_lab.xml EX-101.LAB 242976
10 TAXONOMY EXTENSION PRESENTATION LINKBASE ormp-20111130_pre.xml EX-101.PRE 96579
11 TAXONOMY EXTENSION DEFINITION LINKBASE ormp-20111130_def.xml EX-101.DEF 20832
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-50298 | Film No.: 12523903
SIC: 2834 Pharmaceutical Preparations